<code id='290311167D'></code><style id='290311167D'></style>
    • <acronym id='290311167D'></acronym>
      <center id='290311167D'><center id='290311167D'><tfoot id='290311167D'></tfoot></center><abbr id='290311167D'><dir id='290311167D'><tfoot id='290311167D'></tfoot><noframes id='290311167D'>

    • <optgroup id='290311167D'><strike id='290311167D'><sup id='290311167D'></sup></strike><code id='290311167D'></code></optgroup>
        1. <b id='290311167D'><label id='290311167D'><select id='290311167D'><dt id='290311167D'><span id='290311167D'></span></dt></select></label></b><u id='290311167D'></u>
          <i id='290311167D'><strike id='290311167D'><tt id='290311167D'><pre id='290311167D'></pre></tt></strike></i>

          knowledge

          knowledge

          author:explore    Page View:284
          Franklin faces
          Adobe

          Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to invest in privately held startups.

          The bank announced Wednesday that it has closed its first-ever life sciences fund, called West Street Life Sciences I. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

          advertisement

          First-time funds have been difficult to raise during the biotech downturn. Last year, around $11.6 billion was raised by 183 new VC funds, which was the lowest fundraising total for first-timers since 2013, according to Pitchbook. Around $25.6 billion had been raised by 556 first-time funds in 2022.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Health tech investors get more selective as pandemic boom fades
          Health tech investors get more selective as pandemic boom fades

          AdobeVenturefirmsbackinghealthtechstartupsaretelegraphingcautiousoptimismfor2024,advisingstartupstoe

          read more
          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more

          STAT Readout: Friday, Oct. 20 biotech updates

          SuzanneKreiter/GlobestaffWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourb